H22-Luc-hGPC3

PDF 받기

Strain Information

검증 데이터

1. In vitro Expression of H22-Luc-hGPC3 cell line

hGPC3 expression was measured in H22-Luc-hGPC3 cell by FACS . FACS results showed that significant hGPC3 expression on the H22-Luc-hGPC3 cell line.

image.png

Figure 1 hGPC3 expression in H22-Luc-hGPC3 cell line

2. Characterization of in vivo growth kinetics


To verify tumor formation of H22-Luc-hGPC3 cell line, cells were subcutaneously inoculated into female balb/c mice.

image.png

Figure 2. Tumor growth curve of H22-Luc-hGPC3 allogeneic model (n=5)

image.pngimage.png

Figure 3. Body weight curve of H22-Luc-hGPC3 allogeneic model (n=5)

3. Expression of hGPC3 in tumors

To verify the hGPC3 protein expression, the tumors were dissected and separated for single cell suspension when he tumor volume is 500-1000mm3. Robust hGPC3 protein expression can be detected in the humanized modified tumors.

image.png

Figure 4. The expression of hGPC3 in humanized modified tumors by FACS



Related Strain(s)

당신은 또한 좋아할 수 있습니다

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

조회
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

조회